rescriptors in a sentence

1. Rescriptor ( delavirdine )-- Pharmacia & AMP; Upjohn Inc.
2. Stephen H . West and Wilt L . Idema translated the title as " Rescriptor-in-waiting Bao ".
3. Rescriptor is available in the U . S . and Canada under a special program while the FDA review is being conducted.
4. An FDA advisory panel recently deadlocked on a recommendation for Rescriptor, leaving a decision on approval up to the FDA itself.
5. Rescriptor is the first HIV treatment from Pharmacia & AMP; Upjohn, although company officials say it won't be the last.
6. It's difficult to find rescriptors in a sentence.
7. Pharmacia & AMP; Upjohn's delavirdine, approved Friday, will be on pharmacy shelves within a month under the brand name Rescriptor.
8. Pharmacia & AMP; Upjohn's new AIDS drug Rescriptor failed to win a clear recommendation today from a Food and Drug Administration advisory panel.
9. Last March and April, the FDA approved Viracept and Rescriptor, and CMS officials said they began using them almost immediately, making costs soar.
10. Pharmacia & AMP; Upjohn Inc . said it is supplying the experimental HIV drug Rescriptor to U . S . patients for whom other therapies failed.
11. The company's decision follows a recent similar move by Pfizer to freeze the price of its two AIDS drugs, Viracept and Rescriptor, for two years.
12. The most recent approval, Boehringer Ingelheim Pharmaceuticals Inc .'s nevirapine, and Rescriptor both are members of a new class of AIDS drugs called non-nucleoside reverse transcriptors.
13. The drug, to be sold as Rescriptor Tablets if cleared by the agency, has a sustained ability to combat HIV when used in combination with other approved treatments, studies show.
14. When all the patients-- including those who dropped out of any arm of the study-- were analyzed together, there was no significant long-term benefit shown for Rescriptor.
15. When all the patients-- including those who dropped out of any arm of the study-- were analyzed together, there was no significant benefit shown for Rescriptor, the company said.
16. "We have been disappointed to find that the data being presented today offer little evidence to support the efficacy of Rescriptor, " a coalition of activist groups said in a statement.
More:   1  2